.
MergerLinks Header Logo

New Deal


Announced

Completed

OMERS-backed Omers Growth Equity, Fidelity Management & Research Company and other current investors led $124m funding round in Aledade.

Financials

Edit Data
Transaction Value£99m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Cross Border

Private

Friendly

Minority

Private Equity

Single Bidder

Health Care Services

health care solutions

United States

Acquisition

Venture Capital

Completed

Synopsis

Edit

OMERS-backed Omers Growth Equity, Fidelity Management & Research Company, an investment advisor to Fidelity's family of mutual funds, and other current investors led $124m funding round in Aledade, a physician enablement company. “When we started Aledade nearly a decade ago, we made a bet that if we empowered primary care doctors with the right insights, technology, and contracts that paid for value, we could improve patient outcomes, cut wasteful spending, and create a scalable business model for these practices and Aledade to thrive. With this financing, Aledade is extremely well-positioned in this market environment to accelerate our work to meet patients where they are, especially in Medicare Advantage, and seize new opportunities to expand wraparound patient care services. Difficult market conditions can create exceptional opportunities for strong businesses to get stronger and that is our plan,” Farzad Mostashari, Aledade MD, CEO and co-founder.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US